Wound Healing

1. Economic impact of using carboxymethylcellulose dressing and gauze in the management of venous leg ulcers in Germany and the US.

Presented at the Symposium on Advanced Wound Care and Medical Research Forum, Florida, May 2004.

2. Economic impact of using carboxymethylcellulose dressing and gauze in the management of surgical wounds healing by secondary intention in the UK and US.

Presented at the 2nd World Union Of Wound Healing Societies Meeting, Paris, July 2004

3. Cost effectiveness of using carboxymethylcellulose dressing compared with gauze in the management of exuding venous leg ulcers in Germany and the US.

Authors: JF Guest, FJ Ruiz, A Mihai & A Lehman.
Source: Current Medical Research and Opinion 2005; 21(1): 81-92

View Abstract

4. Modelling the cost implications of using carboxymethylcellulose dressing compared with gauze In the management of surgical wounds healing by secondary intention in the US and UK.

Authors: JF Guest & FJ Ruiz.
Source: Current Medical Research and Opinion 2005; 21(2): 281-290.

View Abstract

5. Costs and consequences of using Hydrofiber dressing and gauze in the management of surgical wound healing.

Presented at the World Conference on Surgical Patient Care, Barcelona, September 2005

6. Modern versus gauze - how do the sums add up? Aquacel use in surgical wounds and venous leg ulcers.

Presented at a satellite conference at the European Wound Management Association (EWMA), Stuttgart, September 2005

7. Modelling the cost-utility of bio-electric stimulation therapy (Posifect) compared to standard care in the treatment of elderly patients with chronic non-healing wounds in the UK.

Authors: JP Clegg & JF Guest.
Source: Current Medical Research and Opinion 2007: 23(4): 871-883.

View Abstract

8. Cost-utility of bio-electric stimulation therapy (Posifect) compared to standard care in the treatment of elderly patients with chronic non-healing wounds in the UK.

Presented at the 17th Conference of the European Wound Management Association (EWMA), Glasgow, May 2007 and published in EWMA Journal 2007; 7 (May Supplement): 77.

9. Cost-effectiveness of amelogenin in the treatment of hard-to-heal venous leg ulcers in the UK.

Presented at the 18th Conference of the European Wound Management Association (EWMA), Lisbon, May 2008 and published in EWMA Journal 2008; 8 (May Supplement): 286.
.